e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for
Pseudomonas aeruginosa
IgG response
Sladjana Skopelja-Gardner, Jomkuan Theprungsirikul, Rachel E. Meagher, Cathleen M. Beliveau, Katherine E. Bradley, Meade Avery, Emily Henkle, Sarah Siegel, Alex H. Gifford, Kevin L. Winthrop, William F.C. Rigby
Source:
Eur Respir J, 53 (2) 1801891; 10.1183/13993003.01891-2018
Journal Issue:
February
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Sladjana Skopelja-Gardner, Jomkuan Theprungsirikul, Rachel E. Meagher, Cathleen M. Beliveau, Katherine E. Bradley, Meade Avery, Emily Henkle, Sarah Siegel, Alex H. Gifford, Kevin L. Winthrop, William F.C. Rigby. Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for
Pseudomonas aeruginosa
IgG response. Eur Respir J, 53 (2) 1801891; 10.1183/13993003.01891-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
Source: Eur Respir J 2007; 29: 965-968
Year: 2007
Sputum neutrophil elastase associates with microbiota and
Pseudomonas aeruginosa
in bronchiectasis
Source: Eur Respir J, 56 (4) 2000769; 10.1183/13993003.00769-2020
Year: 2020
The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006
Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Oral presentation: Neutrophil elastase plays a dual role in host lung defense against Pseudomonas aeruginosa infection
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis
Source: Eur Respir J 2009; 34: 1079-1085
Year: 2009
Mechanisms of induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin
Source: Eur Respir J 2004; 24: Suppl. 48, 107s
Year: 2004
Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007
In vivo
evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
Source: Eur Respir J 2007; 30: 1167-1172
Year: 2007
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006
Targeting iron uptake to control Pseudomonas aeruginosa infections in cystic fibrosis
Source: Eur Respir J 2013; 42: 1723-1736
Year: 2013
The role of mannose-binding lectin in pneumococcal infection
Source: Eur Respir J 2013; 41: 131-139
Year: 2013
Human airway epithelial cell response to
Pseudomonas aeruginosa
virulence factors preceded or not by
Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Azithromycin protects bronchial epithelial integrity after
Pseudomonas aeruginosa
infection independent of bactericidal activity
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
IL-10 induced T-cell tolerance to
Aspergillus fumigatus
and
Pseudomonas aeruginosa
in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 8s
Year: 2001
Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients?
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018
Host response to transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2004; 23: 493-494
Year: 2004
Panobacumab, a fully human monoclonal antibody for ventilator associated pneumonia caused by Pseudomonas aeruginosa
Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept